Kancera AB buy melinda
Start price
27.11.21
/
50%
€0.69
Target price
27.11.22
€1.00
Performance (%)
-76.02%
End price
28.11.22
€0.17
Summary
This prediction ended on 28.11.22 with a price of €0.17. Massive losses of -76.02% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Kancera AB | - | - | - |
iShares Core DAX® | -3.033% | 0.651% | 12.268% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% |
According to melinda what are the pros and cons of Kancera AB for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Kancera Ab diskutieren
Buy mit Kursziel 1,0
In the thread Trading Kancera Ab
Die von melinda gewählte maximale Laufzeit wurde überschritten